KIMS Hospitals

Secunderabad, India Founded: 1999 • Age: 27 yrs Listed
Multispeciality secondary and tertiary care is provided by hospital chains.
Request Access
Report Incorrect Data
Page last updated

About KIMS Hospitals

KIMS Hospitals is a publicly listed company based in Secunderabad (India) founded in 1999 by Bhaskara Rao Bollineni. Multispeciality secondary and tertiary care is provided by hospital chains. KIMS Hospitals has raised $62.46 million across 6 funding rounds from investors including Avendus, General Atlantic and Quadria Capital. The company has 6,490 employees. KIMS Hospitals has completed 3 acquisitions, including Kingsway Hospitals, Queens NRI Hospital and Sunshine Hospitals. KIMS Hospitals was last valued at $325.03 million in June 2018. Its chief executive, as recorded, is Abhinay Bollineni. Its website kimshospitals.com draws about 357 thousand monthly visits. Its Indian entity Krishna Institute Of Medical Sciences Limited reported revenue of ₹3,933 Cr. KIMS Hospitals offers products and services including Cardiology Services, Oncology Services, Neurosciences, Organ Transplantation, and Orthopedic Services. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Its competitors include Narayana Health, Fortis Healthcare and Apollo Hospitals; 1 of its 3 listed competitors has raised funding.

Company details

KIMS Hospitals was established in 1999 in Secunderabad, India, within the healthcare sector. A network of multispeciality facilities is operated, focusing on secondary and tertiary care. Services encompass neurosciences, robotic procedures, reproductive medicine, dental care, oncology, organ transplantation including heart and lung, and mother-child care. Operations are centered in India, serving regional patient needs.

  • Headquarters Secunderabad, India
  • Employees 6,490
  • Founders Bhaskara Rao Bollineni
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website kimshospitals.com
  • Social LinkedIn X Facebook
  • Legal Name Krishna Institute Of Medical Sciences Limited
Operational Areas
Healthcare → Hospitals & Clinical Care
Key Metrics
  • Market Cap
    ₹30,705 Cr

    KIMS · NSE

  • Share Price
    ₹723.00

    -1.10% today

  • Revenue
    ₹3,905 Cr

    FY 2025-26 · +28.7% YoY

  • EBITDA
    ₹803 Cr

    Margin 20.6%

  • Net Profit
    ₹248 Cr

    FY 2025-26 · -29.3% YoY

  • P/E (TTM)
    149.1x

    P/B 8.3x

  • ROE
    11.0%

    ROCE 9.5%

  • Debt / Equity
    1.55

    Interest cover 41.4x

  • Total Equity Funding
    $62.46M (USD)

    in 6 rounds

  • Latest Funding Round
    $12.47M (USD), Series B

    Jun 2018

  • Investors
    Avendus

    & 11 more

  • Employee Count
    6,490
  • Investments & Acquisitions
    Kingsway Hospitals

    & 2 more

Products & Services of KIMS Hospitals

KIMS Hospitals offers a comprehensive portfolio of products and services, including Cardiology Services, Oncology Services, Neurosciences, Organ Transplantation, and Orthopedic Services.

Cardiology Services
Cardiac Care

Provides diagnosis and treatment for heart conditions using advanced technology.

Oncology Services
Cancer Treatment

Offers medical, surgical, and radiation therapies for various cancers.

Neurosciences
Neurological Care

Delivers treatment for brain and nerve disorders through specialized centers.

Organ Transplantation
Surgical Services

Performs transplants for organs like kidney and liver with expert care.

Orthopedic Services
Musculoskeletal Care

Handles joint replacements and trauma with rehabilitation support.

Pediatric Services
Child Health

Focuses on care for children in areas like cardiology and oncology.

Gastroenterology
Digestive Health

Treats gastrointestinal issues with endoscopy and surgical options.

Fertility Services
Reproductive Care

Provides IVF and infertility treatments through dedicated centers.

Funding Insights of KIMS Hospitals

KIMS Hospitals has successfully raised a total of $62.46M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $12.47 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $62.46M
  • Total Rounds 6
  • Last Round Series B — $12.47M
  • First Round $1.04M

    (Dec 2006)

  • Investors Count 12

All 6 funding rounds of KIMS Hospitals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2018$12.47MSeries B$325.03MGeneral Atlantic
Krishnaiah Bollineni
Nov 2017$9.2MDebt – Conventional––
Avendus
Jun 2014$36MSeries B$138.34MICICI Venture
Krishnaiah Bollineni, Avendus
Aug 2009$12.83MSeries A$•••••Quadria Capital, Ibof Investment Management
Bollineni Ramanaiah Memorial Hospitals
Apr 2008$118,145Angel Round$•••••Sushruth, Sudhakar Kanthamneni
KCH Subba Rao
Dec 2006$1.04MAngel Round$•••••K Hari Babu
Bhaskara Rao Bollineni
Valuation history
DateValuationStage
Jun 2018$325.03M••••••••
Jun 2014$138.34M••••••••
Aug 2009$•••••••••••••
Apr 2008$•••••••••••••
Dec 2006$•••••••••••••
Premium access

Full valuation and stage history of KIMS Hospitals

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $325.03M (Jun 2018). 12 investors in total: 6 institutional and 6 angel.

Investors in KIMS Hospitals

KIMS Hospitals has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Avendus, General Atlantic and Quadria Capital.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
General Atlantic
Private equity fund focused on global markets
1980generalatlantic.comNew York, United States
ICICI Venture
Alternative asset management and investment services in India.
1988iciciventure.comMumbai, India
Quadria Capital
Healthcare private equity investments focused on Asian markets.
2012quadriacapital.comSingapore, Singapore
Ibof Investment Management
Education & healthcare sector focused VC firm
2009ibof.inDelhi, India
Avendus
Corporate advisory and investment services are provided to clients.
1999avendus.comMumbai, India
Bollineni Ramanaiah Memorial Hospitals
General medical care is delivered through a standalone hospital facility.
Hyderabad, India

Krishnaiah Bollineni

unknown_878ab35755bd433f9

Sushruth

unknown_4b1c82b4376349118

Sudhakar Kanthamneni

unknown_943ce1b2bed249848

KCH Subba Rao

unknown_bd72ed440f71428e9
Premium access

Investor details for KIMS Hospitals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Krishna Institute Of Medical Sciences Limited (KIMS Hospitals)

Krishna Institute Of Medical Sciences Limited is the primary company behind KIMS Hospitals. The boards of the 6 registered companies of KIMS Hospitals currently have 22 directors; the longest-serving is Bhaskara Rao Bollineni, appointed in 2002. 81 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bhaskara Rao Bollineni
DIN 00008985
Managing Director01 Nov 200224 yrsKrishna Institute Of Medical Sciences Limited, Kims Cuddles Private Limited
Dandamudi Anitha
DIN 00025480
Whole-time director21 Mar 200818 yrs 7 moKrishna Institute Of Medical Sciences Limited
Ravi Shekhar Yellamanchili
DIN 05244091
Director31 Mar 201214 yrs 7 moKims Super Speciality Hospital Private Limited
Kamla Yalmanchili
DIN 00523000
Director28 Jan 201313 yrs 9 moKims Super Speciality Hospital Private Limited
Sunand Surapaneni
DIN 01643850
Director24 Jun 201511 yrs 4 moKims Hospital Enterprises Private Limited
Sudhakar Gajjala
DIN 07257445
Director03 Sep 201511 yrs 2 moKims Hospital Kurnool Private Limited
Rafiq Ahmed Kodumuru
DIN 07932674
Managing Director07 Sep 20179 yrs 2 moKims Hospital Kurnool Private Limited
Veera Kishore Reddy Sane
DIN 03492323
Director01 Apr 20197 yrs 7 moKims Hospital Kurnool Private Limited
Chebrolu Harini
DIN 00356392
Director01 Apr 20197 yrs 7 moKims Hospital Kurnool Private Limited, Kims Cuddles Private Limited, Kims Hospital Enterprises Private Limited
Bollineni Abhinay
DIN 01681273
Director01 Apr 20197 yrs 7 moKims Hospital Kurnool Private Limited, Kims Manavata Hospitals Private Limited, Krishna Institute Of Medical Sciences Limited, Kims Cuddles Private Limited, Kims Hospital Enterprises Private Limited
Rajeswara Rao Gandu
DIN 05339318
Director14 Dec 20196 yrs 10 moKims Hospital Enterprises Private Limited
Saumen Chakraborty
DIN 06471520
Director08 Jan 20215 yrs 9 moKrishna Institute Of Medical Sciences Limited
Venkata Ramudu Jasthi
DIN 03055480
Director08 Jan 20215 yrs 9 moKrishna Institute Of Medical Sciences Limited
Rajshekhar Yallamanchli
DIN 09424837
Director04 Dec 20214 yrs 11 moKims Super Speciality Hospital Private Limited
Sudheer Vinnamala
DIN 09388621
Director07 Dec 20214 yrs 11 moKims Hospital Enterprises Private Limited
Raj Vasantrao Nagarkar
DIN 01850180
Managing Director11 May 20224 yrs 5 moKims Manavata Hospitals Private Limited
Kodali Venkata Krishna Kumar
DIN 00479923
Director22 Aug 20224 yrs 2 moKims Manavata Hospitals Private Limited
Prameela Rani Yalamanchili
DIN 03270909
Director21 Mar 20233 yrs 7 moKims Hospital Kurnool Private Limited, Krishna Institute Of Medical Sciences Limited
Kaza Ratna Kishore
DIN 01152107
Director21 Mar 20233 yrs 7 moKims Hospital Kurnool Private Limited, Kims Manavata Hospitals Private Limited, Krishna Institute Of Medical Sciences Limited, Kims Hospital Enterprises Private Limited
Adwik Bollineni
DIN 06549059
Director28 Nov 20232 yrs 11 moKrishna Institute Of Medical Sciences Limited
Ashish Mahendra Bhalgat
DIN 10697723
Director06 Aug 20242 yrs 3 moKims Manavata Hospitals Private Limited
Suresh Natwarlal Patel
DIN 07202263
Director04 Jan 20251 yr 10 moKrishna Institute Of Medical Sciences Limited

People of KIMS Hospitals

2 people are tracked at KIMS Hospitals (2 in leadership); the tracked headcount is 6,490.

NameRoleGroup
Bhaskara Rao Bollineni
Founder & Managing DirectorLeadership
Abhinay Bollineni
Chief Executive OfficerLeadership
Premium access

Complete people profiles for KIMS Hospitals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of KIMS Hospitals

KIMS Hospitals is a publicly listed company on the NSE with ticker symbol KIMS in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Jun 2021
  • Listed onBSE: 543307 · NSE: KIMS
  • Listed entityKrishna Institute of Medical Sciences Limited
  • Exchange sectorHealth services
  • ISININE967H01025
  • Share price₹692.95 (-2.39% on the day) · 2026-10-14
  • Market capitalisation₹29,768 Cr
  • Price to earnings137.0
  • EPS (diluted, trailing year)₹5.06
  • Volume (last session)217,779

Financials of KIMS Hospitals

Exchange-reported figures of Krishna Institute Of Medical Sciences Limited, the listed company behind KIMS Hospitals (NSE: KIMS).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹3,905 Cr
+28.6% YoY
EBITDA
₹803 Cr
+1.3% YoY
Profit After Tax
₹248 Cr
-29.3% YoY
Net Worth
₹2,247 Cr
+5.1% YoY
Total Assets
₹7,067 Cr
+37.8% YoY
Total Debt
₹4,253 Cr
+66.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,9053,0352,4982,1981,6511,3301,123
Revenue growth+28.7%+21.5%+13.7%+33.1%+24.1%+18.5%-
EBITDA803793648611522376249
EBITDA margin+20.6%+26.1%+25.9%+27.8%+31.6%+28.3%+22.2%
Profit before tax334558460485457279141
Net profit248351308324335202120
Net profit margin+6.4%+11.6%+12.3%+14.7%+20.3%+15.2%+10.7%
EPS (₹)6.049.6138.7542.0341.5725.9316.00
Balance sheet
Total assets7,0675,1273,4822,6401,6851,210996
Net worth2,2472,1381,8281,6701,387864598
Total debt4,2532,5621,355678257316369
Cash & bank74.7080.5049.0166.3719028445.73
Net working capital29911314115820926155.47
Cash flow
Cash from operations511582521432324356202
Cash from investing(1,452)(1,116)(753)(416)(412)(354)(125)
Cash from financing94054321719.6461.009.82(44.34)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,3441,1801,075998961872797772
Revenue growth (YoY)+39.9%+35.3%+34.9%+29.2%+23.6%+26.6%--
Other income31.8017.4012.305.204.207.1015.3017.80
EBITDA260223196199204193198187
EBITDA margin+19.3%+18.9%+18.2%+19.9%+21.2%+22.1%+24.8%+24.2%
Depreciation12110185.0078.7066.1053.4052.6044.70
Interest65.5083.4068.1056.8045.0032.6026.7025.70
Profit before tax10656.6054.8068.6096.80114134135
Tax30.9019.2021.7016.7024.8028.7027.9042.10
Net profit74.6037.4033.1051.9072.0085.0010692.50
EPS (₹)1.791.041.061.331.671.962.542.22
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,7021,3841,2221,1321,143933790
Revenue growth+22.9%+13.3%+8.0%-1.0%+22.6%+18.1%-
EBITDA466421366364401308206
EBITDA margin+27.4%+30.4%+29.9%+32.2%+35.0%+33.0%+26.1%
Profit before tax353403318337371254146
Net profit265270234252280190121
Net profit margin+15.6%+19.5%+19.1%+22.2%+24.5%+20.3%+15.4%
EPS (₹)6.527.5729.4131.5534.7824.3116.26
Balance sheet
Total assets4,0142,9222,2221,6621,4161,055826
Net worth2,4292,1681,8661,6311,378907624
Total debt1,5267083264.1718.41131186
Cash & bank30.0029.6020.5040.1118025039.48
Net working capital22071.6099.4080.3621123967.73
Cash flow
Cash from operations292294262271284291161
Cash from investing(956)(627)(569)(238)(375)(317)(108)
Cash from financing662339289(15.14)75.9825.37(24.35)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue524484456442430373346348
Revenue growth (YoY)+21.9%+29.5%+31.9%+27.2%+18.4%+14.1%--
Other income41.0030.7017.6014.3012.5012.2035.0020.60
Total expenses400365332314318276237245
EBITDA12411812412811297.50109103
EBITDA margin+23.7%+24.4%+27.1%+28.9%+26.0%+26.1%+31.4%+29.6%
Depreciation30.0027.3025.5022.6020.5017.5015.1014.90
Interest11.8032.8026.8021.6017.8012.508.106.70
Profit before tax12388.8089.1097.8086.1079.70120102
Tax30.4022.3023.2025.3022.6020.9027.0025.40

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,3441,1801,075998961872797772
Revenue growth (YoY)+39.9%+35.3%+34.9%+29.2%+23.6%+26.6%--
Other income31.8017.4012.305.204.207.1015.3017.80
EBITDA260223196199204193198187
EBITDA margin+19.3%+18.9%+18.2%+19.9%+21.2%+22.1%+24.8%+24.2%
Depreciation12110185.0078.7066.1053.4052.6044.70
Interest65.5083.4068.1056.8045.0032.6026.7025.70
Profit before tax10656.6054.8068.6096.80114134135
Tax30.9019.2021.7016.7024.8028.7027.9042.10
Net profit74.6037.4033.1051.9072.0085.0010692.50
EPS (₹)1.791.041.061.331.671.962.542.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,9053,0352,4982,1981,6511,3301,123
Revenue growth+28.7%+21.5%+13.7%+33.1%+24.1%+18.5%-
Other income28.8042.7013.0640.7029.7710.176.08
Total expenses3,1012,2421,8501,5871,129954873
Employee cost682500422346262220198
EBITDA803793648611522376249
EBITDA margin+20.6%+26.1%+25.9%+27.8%+31.6%+28.3%+22.2%
Depreciation28317714712972.6769.5470.61
Interest21510054.5737.2821.8737.3344.43
Profit before tax334558460485457279141
Tax91.9014312411911373.5425.45
Net profit248351308324335202120
Net profit margin+6.4%+11.6%+12.3%+14.7%+20.3%+15.2%+10.7%
EPS (₹)6.049.6138.7542.0341.5725.9316.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital80.0080.0080.0380.0380.0377.5974.49
Reserves & surplus2,1672,0581,7481,5901,307786523
Shareholders' funds (net worth)2,2472,1381,8281,6701,387864598
Minority interest31128126526823.3312.4613.31
Secured loans3,2431,9101,045533161220318
Unsecured loans1,01065231014595.7595.9051.14
Total debt4,2532,5621,355678257316369
Total liabilities7,0675,1273,4822,6401,6851,210996
Assets
Gross block6,6574,0893,0192,2231,3291,1901,103
Net block5,7103,3482,4341,7661,005931916
Capital work in progress6061,21460047720.769.242.23
Investments10399.1015767.893320.000.00
Inventories96.9064.0049.4442.8736.4324.0930.38
Sundry debtors554395294253129110132
Cash & bank balances74.7080.5049.0166.3719028445.73
Loans & advances19613571.6147.8638.2632.8411.45
Total current assets922675464410393451220
Total current liabilities623562323252185190164
Net working capital29911314115820926155.47
Total assets7,0675,1273,4822,6401,6851,210996
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash56.0046.9061.6125.6352.1340.518.06
Net cash from operating activities511582521432324356202
Net cash from investing activities(1,452)(1,116)(753)(416)(412)(354)(125)
Net cash from financing activities94054321719.6461.009.82(44.34)
Net change in cash(0.60)9.10(14.72)35.98(26.50)11.6232.45
Closing cash74.7080.5049.0166.3719028445.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+28.7%+21.5%+13.7%+33.1%+24.1%+18.5%-
EBITDA growth+1.3%+22.4%+6.1%+17.1%+38.8%+50.6%-
PBT growth-40.2%+21.4%-5.2%+6.1%+63.7%+98.6%+9998.0%
Net income growth-29.3%+13.9%-4.9%-3.2%+65.7%+68.3%-
Revenue CAGR (3Y)+21.1%+22.5%+23.4%+25.1%+21.6%+26.1%+25.6%
EBITDA CAGR (3Y)+9.6%+15.0%+19.9%+34.8%+83.4%+74.7%+28.5%
Profitability & leverage
Net income margin+6.2%+13.7%+13.5%+16.7%+20.8%+15.5%+10.3%
Return on capital employed+9.5%+16.3%+18.4%+25.9%+32.8%+25.5%+17.6%
Return on net worth+11.0%+20.9%+19.2%+23.9%+29.7%+23.3%+16.8%
Debt / equity1.550.990.580.310.250.470.62
Long-term debt / equity1.350.890.530.280.200.370.53
Interest cover41.3516.3010.897.744.8712.1924.84
Efficiency & per share
Fixed asset turnover0.730.850.951.241.311.161.07
Inventory turnover48.5353.5154.1355.4354.5548.8339.23
Debtors turnover8.228.809.1311.5313.8510.998.79
EPS (₹)6.049.6138.7542.0341.5725.9316.00
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)56.1953.45228.46208.62173.35111.3280.25
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue524484456442430373346348
Revenue growth (YoY)+21.9%+29.5%+31.9%+27.2%+18.4%+14.1%--
Other income41.0030.7017.6014.3012.5012.2035.0020.60
Total expenses400365332314318276237245
EBITDA12411812412811297.50109103
EBITDA margin+23.7%+24.4%+27.1%+28.9%+26.0%+26.1%+31.4%+29.6%
Depreciation30.0027.3025.5022.6020.5017.5015.1014.90
Interest11.8032.8026.8021.6017.8012.508.106.70
Profit before tax12388.8089.1097.8086.1079.70120102
Tax30.4022.3023.2025.3022.6020.9027.0025.40
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,7021,3841,2221,1321,143933790
Revenue growth+22.9%+13.3%+8.0%-1.0%+22.6%+18.1%-
Other income56.6067.5018.2023.5024.179.627.09
Total expenses1,236963857768743625584
Employee cost291236220187174147137
EBITDA466421366364401308206
EBITDA margin+27.4%+30.4%+29.9%+32.2%+35.0%+33.0%+26.1%
Depreciation86.1057.7058.1045.3044.9244.6042.66
Interest83.6027.607.404.808.9118.3323.76
Profit before tax353403318337371254146
Tax92.0010082.9084.8492.6365.6125.40
Net profit265270234252280190121
Net profit margin+15.6%+19.5%+19.1%+22.2%+24.5%+20.3%+15.4%
EPS (₹)6.527.5729.4131.5534.7824.3116.26
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital80.0080.0080.0080.0380.0377.5974.49
Reserves & surplus2,3492,0881,7861,5511,298830549
Shareholders' funds (net worth)2,4292,1681,8661,6311,378907624
Secured loans1,4537083264.1718.4178.77183
Unsecured loans73.500.000.000.000.0052.563.41
Total debt1,5267083264.1718.41131186
Total liabilities4,0142,9222,2221,6621,4161,055826
Assets
Gross block1,9541,1551,008889827775711
Net block1,534773674612592582559
Capital work in progress11653029215.9713.197.602.23
Investments1,5231,2261,062826542213178
Inventories39.8026.3022.1019.2425.9916.4721.71
Sundry debtors27818714912087.3873.0099.15
Cash & bank balances30.0029.6020.5040.1118025039.48
Loans & advances85.6056.1048.3016.5838.1527.738.90
Total current assets434299240196331367169
Total current liabilities214228140116120128102
Net working capital22071.6099.4080.3621123967.73
Total assets4,0142,9222,2221,6621,4161,055826
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash26.1020.5038.1019.8634.5934.476.26
Net cash from operating activities292294262271284291161
Net cash from investing activities(956)(627)(569)(238)(375)(317)(108)
Net cash from financing activities662339289(15.14)75.9825.37(24.35)
Net change in cash(1.00)5.60(17.60)18.24(14.73)0.1228.21
Closing cash30.0029.6020.5040.1118025039.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+22.9%+13.3%+8.0%-1.0%+22.6%+18.1%-
EBITDA growth+10.7%+15.2%+0.4%-9.2%+30.3%+49.4%-
PBT growth-12.5%+26.7%-5.7%-9.1%+45.9%+73.6%+9998.0%
Net income growth-1.7%+15.3%-7.1%-10.2%+47.9%+56.1%-
Revenue CAGR (3Y)+14.6%+6.6%+9.4%+12.7%+17.4%+14.1%+13.8%
EBITDA CAGR (3Y)+8.6%+1.7%+5.9%+20.9%+94.5%+67.1%+21.7%
Profitability & leverage
Net income margin+15.3%+21.9%+19.3%+22.3%+24.4%+20.2%+15.3%
Return on capital employed+12.6%+16.8%+16.8%+22.2%+30.5%+25.8%+19.6%
Return on net worth+11.3%+15.0%+13.5%+16.8%+24.2%+21.4%+18.1%
Debt / equity0.490.260.090.010.070.210.33
Long-term debt / equity0.380.210.070.000.030.140.27
Interest cover22.027.602.411.512.506.9714.56
Efficiency & per share
Fixed asset turnover1.091.281.291.321.431.261.14
Inventory turnover51.4857.1959.1250.0653.8648.8638.84
Debtors turnover7.318.249.1010.9214.2610.847.93
EPS (₹)6.527.5729.4131.5534.7824.3116.26
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)60.7254.20233.30203.79172.13116.9383.75

Investments & Acquisitions by KIMS Hospitals

KIMS Hospitals has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Kingsway Hospitals, Queens NRI Hospital and Sunshine Hospitals.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Queens NRI Hospital
Multi-specialty hospital services are delivered in Visakhapatnam.
queensnrihospital.comVisakhapatnam, India1994Jul 2024$8.98M
Kingsway Hospitals
Multispecialty hospital services are operated in Nagpur, India.
kingswayhospitals.comNagpur, India2017Aug 2022$10.04M
Sunshine Hospitals
Multispeciality hospitals chain offering diverse medical services.
sunshinehospitals.comBhubaneswar, India2009Oct 2021$48M
Premium access

Complete acquisition details for KIMS Hospitals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of KIMS Hospitals

8 dated milestones of KIMS Hospitals across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded KIMS Hospitals is founded.
  2. Funding First funding round of $1.0M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $12.5M.
  5. IPO Lists on the stock exchange (IPO).
  6. Acquisition Acquires Sunshine Hospitals.
  7. Acquisition Acquires Kingsway Hospitals.
  8. Acquisition Acquires Queens NRI Hospital.

Competitors of KIMS Hospitals

KIMS Hospitals has 3 listed competitors in our database, 1 of them funded. They include Narayana Health, Fortis Healthcare and Apollo Hospitals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Narayana Health
narayanahealth.org2000Bengaluru, India$148.2M8,145
A chain of multi-specialty hospitals is operated in India.
Fortis Healthcare
fortishealthcare.com1996Gurugram, India1,565
Multi-specialty hospital services are provided across India by Fortis Healthcare.
Apollo Hospitals
apollohospitals.com1983Chennai, India21,350
Chain of multispecialty hospitals
Premium access

Detailed competitors of KIMS Hospitals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of KIMS Hospitals

The website of KIMS Hospitals (kimshospitals.com) receives about 357.2K visits a month and ranks #91,559 among all websites worldwide, #2,620 in Health.

  • Monthly visits
    357.2K

    ▼ 19.9% vs previous month

  • Unique visitors
    142K

    per month

  • Global rank
    #91,559

    among all websites

  • Category rank
    #2,620

    Health · Health

Similar websites

Websites whose visitors overlap most with KIMS Hospitals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
KIMSHEALTH
kimshealth.org
100%
161.9K#275,719View details
Yashoda Hospitals
yashodahospitals.com
99%
1.2M#48,828View details
sriaas.in
sriaas.in
92%
#2,056,125–
SkeDoc
skedoc.com
91%
198.8K#256,103View details
Pace Hospital
pacehospital.com
89%
500.2KView details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for KIMS Hospitals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as KIMS Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloudnine
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
HCG
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 36.59 MUSD 270.51 M321
Medanta
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kims Hospitals

KIMS: Q2 REVENUE 13.4B RUPEES VS 9.6B (YOY)
Exchange Update • 4 days ago
KIMS: Q2 CONS NET PROFIT 750M RUPEES VS 669M (YOY)
Exchange Update • 4 days ago
KIMS: Q2 EBITDA 2.6B RUPEES VS 2.04B (YOY); Q2 EBITDA MARGIN 19.36% VS 21.23% (YOY)
Exchange Update • 4 days ago
Krishna Institute Of Medical Sciences: To Acquire 6% Stake In Ushahkal Abhinav Specialty Hospital For ₹15 Crore; Aims To Improve Operational Efficiency By October 31, 2026.
Exchange Update • 1 month ago
Grapevine: Welspun, Macquarie, Ultraviolette, Speciale Invest, others in news
VCCircle • 2 months ago
Krishna Institute of Medical Sciences allots 77.02 lakh convertible warrants | Capital Market News - Business Standard
Business Standard • 2 months ago
KIMS to operate 250-bed Arete Hospital in Hyderabad under 5-year O&M deal - CNBC TV18
CNBCTV18 • 2 months ago
Buy Krishna Institute of Medical Sciences; target of Rs 850: Prabhudas Lilladher
Moneycontrol • 3 months ago
KIMS: Q1 revenue up 36% year-on-year, strong EBITDA, and major debt reduction via QIP
Quartr • 3 months ago
Krishna Institute of Medical Sciences consolidated net profit declines 47.20% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 3 months ago
Premium access

Complete news archive for KIMS Hospitals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KIMS Hospitals

KIMS Hospitals was founded in 1999 and raised its 1st funding round 7 years after it was founded.

KIMS Hospitals is headquartered in Secunderabad, India. It is registered at Secunderabad, Telangana, India.

Abhinay Bollineni is the CEO of KIMS Hospitals, as recorded in our data.

KIMS Hospitals is a funded company, having raised a total of $62.46M across 6 funding rounds to date. The company's 1st funding round was a Angel Round of $1.04M, raised on Dec 2006.

KIMS Hospitals has 6,490 employees.

The primary company behind KIMS Hospitals, Krishna Institute Of Medical Sciences Limited, reported revenue of ₹3,933 Cr for FY 2026, up 29% year on year.

KIMS Hospitals was established in 1999 in Secunderabad, India, within the healthcare sector. A network of multispeciality facilities is operated, focusing on secondary and tertiary care. Services encompass neurosciences, robotic procedures, reproductive medicine, dental care, oncology, organ transplantation including heart and lung, and mother-child care. Operations are centered in India, serving regional patient needs.

KIMS Hospitals's top competitors include Fortis Healthcare, Apollo Hospitals and Narayana Health.

KIMS Hospitals offers Cardiology Services, Oncology Services, Neurosciences, Organ Transplantation, and 4 more products and services.

Yes, KIMS Hospitals is publicly traded on NSE under the ticker symbol KIMS.

KIMS Hospitals has made 3 acquisitions, including Kingsway Hospitals, Queens NRI Hospital, and Sunshine Hospitals.

KIMS Hospitals has 12 investors. Key investors include Avendus, General Atlantic, Quadria Capital, ICICI Venture, and Ibof Investment Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available